In a multicenter study we compared three tests for ischemic myocardial injury (lMl):a new, automated enzyme immunoassay for S-troponin T (S-TNT; Boehnnger Mannhelm) and two S-creatine kinase (CK) isoenzyme MB assays (mass and catalytic concentrations). For critical evaluation of clinical sensitivity, we studied 243 cases with an IMI prevalence of 43% and an 18% prevalence of cases with unstable angina. Relative peak values of S-TNT and S-CK-MB (mass) after onset of pain were fourto fivefold higher than S-CK-MB (catalytic) results. Increases of S-TNT and S-CK-MB (mass), even though still within their reference ranges, indicated minor myocardial damage in about one-third of the cases primarily classified as unstable angina. The diagnosticwindow for S-TNT ranged from hours to weeks after the acute episode. The time courses were frequently biphasic, with the initial S-TNT peak closely paralleling that of the mass concentrations of S-CK-MB. With a biological half-life for S-TNT of 2 h, the prolonged increases in S-TNT indicate a continuous release of S-TNT from necrotizing cells. Clinical specificities of S-TNT and S-CK-MB (mass) were greater than that of S-CK-MB (catalytic), even in the presence of 30% to 40% severe skeletal muscle injuries. in patients in their coronary care units who were thought to have had IMI. Further, we included samples from stable angina patients and some nonischemic heart disease patients from medical departments because it is not realistic to evaluate clinical sensitivity and specificity with only definite AMI vs non-AMI patients. Consequently, we decided to compare test performances under "worst-case" conditions by including relatively large numbers of borderline cases such as unstable angina in the IMI group and severe skeletal muscle injuries in the reference group. S-TNT and S-CK-MB (cat) were determined on all samples and S-CK-MB (mass) on all samples from three of the hospitals (1, 3, 5). post-AMI, patients with an AMI older than 48 h; S-CK-MB (cat), creatine kinase isoenzyme MB in serum, catalytic activity concentration; S-CK-MB (masa), creatine kinaae isoenzyme MB in serum, mass concentration; S-TNT, cardiac troponin Tin serum; and IHD, ischemic heart disease.
the kinetics of concentration changes in blood depend on time elapsed until reperfusion and on the degree of reperfusion of the infarcted zone (6) . A specific, automated enzyme immunoassay of troponin T, based on use of monoclonal antibodies with <2% cross-reactivity with skeletal muscle troponin T, has recently been developed by Boehringer
Mannheim
(Mannheim, F.R.G.) for routine use (7) . The purpose of this multicenter study was toevaluate this assay and compare the diagnostic performance of S-troponin T (S-TNT) with that of 5-creatine kinase (CK; EC 2.7.3.2) isoenzyme MB [catalytic (cat) and mass concentrations] in suspected cases of IMI. Five hospitals cooperated in collecting timed serial samples after onset of acute symptoms in patients in their coronary care units who were thought to have had IMI. Further, we included samples from stable angina patients and some nonischemic heart disease patients from medical departments because it is not realistic to evaluate clinical sensitivity and specificity with only definite AMI vs non-AMI patients. Consequently, we decided to compare test performances under "worst-case" conditions by including relatively large numbers of borderline cases such as unstable angina in the IMI group and severe skeletal muscle injuries in the reference group. S-TNT and S-CK-MB (cat) were determined on all samples and S-CK-MB (mass) on all samples from three of the hospitals (1, 3, 5).
MaterIals and Methods

Subjects
The IMI group (AMI + MMD) comprised 87 cases of AMI, classified according to the World Health Organization criteria (8) by characteristic chest pain, unequivocal changes in the electrocardiogram, and increased S-CK (cat) and S-CK-MB (cat). Forty-three cases were primarily classified as unstable angina pectoris (IJAP) on the basis of chest pain at rest or provoked by minimal exertion, a new pattern of chest pain in a previously chronic angina, or both, with or without ST-depression 8Nonstandard abbreviations: 1MI, ischemic myocardial injury; AMI, acute myocardial infarction; MMD, minor myocardial damage; UAP, unstable angina pectoris; SAP, stable angina pectoris; post-AMI, patients with an AMI older than 48 h; S-CK-MB (cat), creatine kinase isoenzyme MB in serum, catalytic activity concentration; S-CK-MB (masa), creatine kinaae isoenzyme MB in serum, mass concentration; S-TNT, cardiac troponin Tin serum; and IHD, ischemic heart disease. 
Blood Sampling
In all IMI-suspected patients, the onset of acute symptoms was established as accurately as possible, and samples were taken from a few hours after admission to weeks after the acute episode (see Figure 1) . One blood sample each was drawn from patients with non-IHD, with SAP (without an angina pectoris attack), or with skeletal injury. Serum samples were stored at -70#{176}C for a maximum of two months until analysis.
Preliminary
experiments showed no considerable losses of S-CK-MB (cat) (12), S-CK-MB (mass), and S-TNT under these conditions.
Methods
S-troponin
T. The troponin T immunoassay (ELISA Troponin(e) T; Boehringer Mannheim) was performed on all samples from all patients studied at each of the five participating centers. This new enzyme immunoassay was carried out in coated tubes by using the microprocessor-controlled Boehringer Mannheim ES 22 photometer. The method is based on a single-step sandwich principle, with streptavidin-coated tubes as the solid phase and two monoclonal anti-human cardiac troponin T antibodies (7) . Tropornn T is bound on different epitopes by the capture and signal antibodies. The capture antibody is biotinylated, binds completely and reproducibly to the streptavidin-coated tube, and is 99% specific for cardiac troponin T (7) . The second antibody is labeled with horseradish peroxidase (EC 1.11.1.7) and has about 20% cross-reactivity with skeletal muscle troponin T. Because of the capture antibody's high specificity, the assay is immunologically specific for cardiac troponin T. However, in samples with high concentrations of skeletal muscle tropornn T, unspecific binding to the tube wall may result in increased S-TNT values. The calibration procedure for assay of human tropomn T is described elsewhere (7) . 
Results
Time series were plotted for all patients thought to have possible IMI. Figure 1 shows the time courses of S-CK-MB (cat), S-CK-MB (mass), and S-TNT in three illustrative cases. Relative concentrations, with the discriminator value set at 1.0 on the ordinate, were plotted as a function of time after onset of acute symptoms. Figure IA shows the pattern for a non-Q-wave AMI in a 69-year-old man. The relative peak value of S-CK-MB (mass) was nearly fivefold that of S-OK-MB (cat). S-TNT showed a typical biphasic course: an initial, continued increase exceeding that of S-CK-MB (mass), and then a prolonged plateau, remaining increased 10-fold at 100 h after onset of symptoms. The diagnostic time window was thus far wider than that of S-CK-MB (cat and mass). Figure 1C presents data for a 49-year-old man (case 2.02, Table 1 )with a previous AMI who was admitted with UAP. The patient had two acute episodes, at time zero and at around 80 h, causing the increases of S-OK-MB (mass) and S-TNT that indicate an initial MMD (17, 18) followed by an AMI, as determined by conventional criteria. The initial peak for S-OK-MB (mass) was considerably higher than that of S-OK-MB (cat), with the latter remaining just below the discriminator value. During subsequent months, this patient had three myocardial infarctions.
Reclassification of 16 cases of UAP as MMD. Time series (e.g., Figure 1) were piotted for all IMI-suspected patients. Unambiguous time curves of S-OK-MB (mass) and of S-TNT, as in Figures 1B, C In Figure 2A and specificity curves were plotted as a function of test value (19, 20) and reflect the different distributions.
The reader can estimate sensitivity and specificity for different discriminator values directly off the scale on the right ordinate of the graph (19, 20) . Based on these curves, a discriminator value of 0.20 pg/L yielded a sensitivity of 96% and a specificity of 98% (Table 2) .
In Figure 2B we replotted the S-TNT data on an expanded abscissa scale toshow the distribution of the 16 MMD cases among the IMI cases (upper field) and of 55 casesof severe skeletal muscle injuries added to the reference group (lower field) for critical evaluation of specificity under worst-case conditions. Of the MMD cases, 75% had peak S-TNT values exceeding the discriminator value of 0.20 tg/L; 80% of the severe skeletal muscle injuries remained S-TNT negative. The clinical specificity in the presence of 29% skeletal muscle injury cases in the reference group decreased to 94%. Figure 2 had returned to normal. For this test we considered it most correct to plot these seven cases in the reference group. In Figure 3A Table 1 ). The lower field shows the distribution of 55 skeletal muscle injury cases added to the reference group: 75% of the skeletal muscle injuries remained S-CK-MB (cat) negative. Clinical specificity in the presence of3l% skeletal muscle injury cases inthe reference group decreased to91%.
S-CK-MB (cat). S-OK-MB (cat) is routinely used as an
S-CK-MB
(mass). As described above, the individual time curves with this assay were used toidentify the 16 MMD casesdescribed in Table 1 . Figure 4A 
20-fold increased values of S-CK-MB (mass).
The reference group comprised 67 of the same cases as in the previous figures. Relative to a discriminator value of 8 ,ug/L, sensitivity was 96% and specificity 100%.
The expanded plot, Figure 48 , shows that about 75% of the MMD cases (upper field) had S-CK-MB (mass) values exceeding the discriminator value of 8 .ig/L; 95% of the added skeletal muscle injury cases (lower field) remained S-CK-MB (mass) negative. The clinical specificity in the presence of 40% severe skeletal muscle injury casesin the reference group decreased to95%. Diagnostic test data may be evaluated inthree different modes: (a) relative to a conventional discriminator value (the position of the discriminator depends on the borderline cases; all our 16 MMD cases were included in all three tests); (b) relative to individual baselines, e.g., convalescence values (see Figure 1B) ; and (c) by nnmeven greater.
The histograms indicate that S-CK-MB (mass) and S-CK-MB (cat) do not measure quite the same component: compared with the IMI frequency distributions of S-CK-MB (cat), those of S-CK-MB (mass) and also of S-TNT were shifted toward considerably greater values. IMI peak values were more than 20-fold the discriminator value in 40% of the caseswith S-TNT, and in 24% of the caseswith S-CK-MB (mass), compared with only 1% with S-CK-MB (cat). This was also apparent from the much steeper decrease of the sensitivity curve of S-CK-MB (cat) with increasing values (see Figure 3A) . The clinical sensitivities and specificities of S-TNT and S-CK-MB (mass) were greater than those of S-CK-MB (cat). Clinical sensitivity of S-CK-MB (cat) inthis study was lower than previously reported (10-12) because the older evaluations had to be based on AMI as classified by conventional criteria. MMD cases could not be so identified and were consequently allocated to the reference groups.
Despite a biological half-life of S-TNT of 2 h (6), the diagnostic time window of S-TNT is unusually wide, ranging from a few hours to several weeks after the acute episode. The biphasic serum changes of S-TNT may be explained by an initial leakage of the minor cytosolic fraction, followed by the prolonged release of the much larger structurally bound troponin T pool from the necrotizing cells (5, 6,22-24). When the myocytes have been depleted of CK-MB, and serum values have returned tonormal, release of troponin T continues. In cases of late admission after onset of the acute episode, a finding of increased S-TNT and normal S-CK-MB (mass) in a sample indicates an IMI of >48 h previously, which should be monitored.
Recent data indicate thatthe biphasic time course of S-TNT is found only in patients with reperfused AM! and that the ratio between the initial peak and the subsequent plateau at [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] h correlates with the duration of ischemia before recanalization and the degree of subsequent reperfusion (5, 6,25).
In routine use, the clinical speciflcities of each of the three tests will depend on the prevalence and degree of skeletal muscle injury cases in the requesting were less for S-TNT and S-CK-MB (mass) than for S-CK-MB (cat). We conclude that the combination of S-TNT and mass concentration S-CK-MB is excellent for the detection of ischemic myocardial injury, including minor myocardial damage.
Time willshow whether S-TNT alone may replace current IMI markers.
